查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128474

呼吸系統市場規模、佔有率、成長、全球產業分析、區域趨勢及2026-2034年預測。

Respiratory Devices Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

呼吸系統市場成長要素

受慢性呼吸系統疾病盛行率上升、健康意識增強以及呼吸護理設備技術不斷進步的推動，全球呼吸設備市場正經歷穩定成長。報告顯示，2025年全球呼吸設備市場規模為264.4億美元。預計該市場將從2026年的276.7億美元成長至2034年的458.4億美元，預測期內複合年成長率（CAGR）為6.51%。 2025年，北美市場佔主導地位，市場佔有率達40.29%，這得益於其完善的醫療基礎設施、較高的診斷率以及主要呼吸設備製造商的強大市場佈局。

呼吸機是醫療設備，旨在透過提供氧氣、監測呼吸功能和輔助通氣來支持患者的呼吸。這些設備廣泛應用於醫院、專科診所和居家醫療機構，用於診斷和治療慢性阻塞性肺病（COPD）、氣喘、睡眠呼吸中止症和其他呼吸系統疾病。

市場定義和範圍

呼吸設備市場涵蓋了用於呼吸系統疾病治療的各種治療設備、診斷和監測設備以及耗材和配件。這些產品包括人工呼吸器、吸入器、霧化器、正壓呼吸器(PAP)設備、肺計量計、脈動式血氧監測儀系統、面罩、氧氣鼻管及相關配件。

該市場涵蓋醫院、門診手術中心、專科診所、居家醫療提供者及其他醫療機構。對攜帶式、人工智慧驅動的家用呼吸設備的需求不斷成長，正在推動這些產品在已開發國家和新興國家醫療保健市場的應用。

市場動態

成長要素

慢性阻塞性肺病（COPD）、氣喘、睡眠呼吸中止症以及感染疾病引起的呼吸系統疾病等病症的日益普遍是推動市場成長的主要因素。空氣污染加劇、吸菸習慣、人口老化以及生活方式的改變，顯著增加了需要診斷和治療呼吸系統疾病的患者數量。此外，新興經濟體醫療基礎設施的持續發展以及人們對早期疾病診斷重要性的認知不斷提高，也為市場擴張提供了支持。

趨勢

推動市場發展的關鍵趨勢之一是呼吸設備技術的日益普及。製造商正迅速推出智慧吸入器、攜帶式人工呼吸器、穿戴式呼吸監測系統和人工智慧診斷解決方案，以改善治療效果並提高患者的用藥依從性。人工智慧與遠端監測技術的融合，使得診斷更加精準，患者管理更加即時，尤其是在慢性呼吸系統疾病的治療方面。

阻礙因素

限制市場成長的主要挑戰之一是熟練的呼吸治療師和訓練有素的醫療保健專業人員短缺，尤其是在開發中國家。此外，患者對長期呼吸治療的依從性差以及先進呼吸設備的高成本也持續阻礙產品在價格敏感型市場的滲透。

新冠疫情的影響

新冠疫情對呼吸設備市場產生了積極影響，呼吸系統併發症的空前激增促使人工呼吸器、氧氣療法設備、脈搏血氧飽和度分析儀、口罩和呼吸監測設備的需求大幅上升。疫情期間及之後，產能擴張和政府對醫療基礎設施的投資進一步加速了市場成長。

細分分析

按產品類別分類，治療設備細分市場主導，預計到2026年將佔全球市場的70.64%。人工呼吸器、正壓通氣（PAP）設備、吸入器和霧化器的需求不斷成長，以及持續的產品創新，將繼續推動該細分市場的成長。診斷和監測設備是第二大細分市場，其成長主要得益於呼吸系統疾病篩檢的不斷成長。

按應用領域分類，預計到2026年，睡眠呼吸中止症領域將以32.37%的市場佔有率引領市場，這主要得益於阻塞型睡眠呼吸中止症症的上升以及先進的PAP治療設備的廣泛應用。鑑於慢性呼吸系統疾病在全球日益加重，慢性阻塞性肺病和氣喘仍然是重要的應用領域。

按終端用戶分類，預計到2026年，居家照護行業將佔市場主導地位，市場佔有率達43.54%，這主要得益於對攜帶式呼吸機、遠端患者監護和家庭醫療保健解決方案的需求不斷成長。醫院和門診手術中心（ASC）由於其較高的患者住院率和重症監護需求，仍將是重要的終端用戶群。

區域分析

預計北美將引領全球呼吸設備市場，2025年市場規模將達106.5億美元，2026年將達111.7億美元。該地區受益於先進的醫療基礎設施、創新呼吸技術的廣泛應用以及呼吸系統疾病的高發生率。預計到2026年，美國市場規模將達到103.8億美元。

預計到 2025 年，歐洲的消費額將達到 86.8 億美元，到 2026 年將達到 90.4 億美元，這得益於 COPD 和氣喘病例的增加、有利的保險報銷政策以及對醫療保健的持續投資。

預計亞太地區市場規模將在2025年達到44.6億美元，2026年達到47億美元。老年人口的成長、醫療基礎設施的不斷改進以及人們對呼吸系統疾病的認知提高，將繼續推動該地區市場的成長。中國、日本和印度仍然是市場擴張的主要驅動力。

在拉丁美洲、中東和非洲，政府採取了一系列旨在改善醫療保健服務、提高疾病意識和加強呼吸系統護理服務的舉措，推動了適度成長。

本報告對全球呼吸設備市場進行了全面分析，包括2025年、2026年和2034年的市場規模、主要成長要素、市場趨勢、阻礙因素、新冠疫情的影響、按類型、應用和最終用戶分類的市場細分、區域分析、競爭格局以及近期行業發展動態。報告還涵蓋了主要市場參與企業的技術進步和策略舉措。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 主要呼吸系統疾病流行：主要國家和地區，2025 年
  • 呼吸設備技術的進步
  • 新產品發布
  • 產業重大發展：合併、收購與合作。
  • 新冠疫情的影響：全球呼吸系統市場

第5章：2021-2034年全球呼吸系統市場分析、洞察與預測

  • 市場分析、洞察與預測：按類型
    • 治療設備
      • 正壓呼吸裝置（PAP）
      • 呼吸道管理裝置
      • 人工呼吸器
      • 吸入器
      • 噴霧器
      • 其他
    • 診斷和監測設備
      • 肺計量計
      • 睡眠多導圖設備
      • 脈搏血氧飽和度分析儀
      • 其他
    • 耗材和配件
      • 面具
      • 鼻導管
      • 其他
    • 市場分析、洞察與預測：按應用領域分類
      • 慢性阻塞性肺病（COPD）
      • 睡眠呼吸中止症
      • 氣喘
      • 感染疾病
      • 其他
    • 市場分析、洞察與預測：按最終用戶分類
      • 醫院和門診手術中心（ASC）
      • 專科診所
      • 居家醫療
      • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美呼吸系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲呼吸系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 德國
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太呼吸系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲呼吸系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲呼吸系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Koninklijke Philips NV
    • Medtronic
    • ResMed, Inc.
    • Fisher & Paykel Healthcare Limited
    • Masimo
    • Getinge AG
    • GE Healthcare
    • Baxter
Product Code: FBI101424

Growth Factors of respiratory devices Market

The global respiratory devices market is witnessing steady growth due to the rising prevalence of chronic respiratory disorders, increasing healthcare awareness, and continuous technological advancements in respiratory care equipment. According to the report, the global respiratory devices market size was valued at USD 26.44 billion in 2025. The market is projected to grow from USD 27.67 billion in 2026 to USD 45.84 billion by 2034, exhibiting a CAGR of 6.51% during the forecast period. In 2025, North America dominated the market with a 40.29% share, supported by a well-established healthcare infrastructure, high diagnosis rates, and the strong presence of leading respiratory device manufacturers.

Respiratory devices are medical equipment designed to assist patients in breathing by delivering oxygen, monitoring respiratory function, or supporting ventilation. These devices are extensively used for the diagnosis and treatment of conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, sleep apnea, and other respiratory disorders across hospitals, specialty clinics, and home healthcare settings.

Market Definition and Scope

The respiratory devices market includes a broad range of therapeutic devices, diagnostic & monitoring devices, and consumables & accessories used for respiratory disease management. These products include ventilators, inhalers, nebulizers, Positive Airway Pressure (PAP) devices, spirometers, pulse oximeters, masks, nasal cannulas, and related accessories.

The market serves hospitals, ambulatory surgical centers (ASCs), specialty clinics, home healthcare providers, and other healthcare facilities. Growing demand for portable, AI-enabled, and home-use respiratory devices is expanding the application scope of these products across developed and emerging healthcare markets.

Market Dynamics

Drivers

The increasing prevalence of respiratory diseases such as COPD, asthma, sleep apnea, and infectious respiratory illnesses is the primary driver of market growth. Rising air pollution, smoking habits, aging populations, and changing lifestyles have significantly increased the number of patients requiring respiratory diagnosis and treatment. In addition, continuous improvements in healthcare infrastructure across emerging economies and growing awareness regarding early disease diagnosis are supporting market expansion.

Trends

A major trend shaping the market is the growing adoption of technologically advanced respiratory devices. Manufacturers are introducing smart inhalers, portable ventilators, wearable respiratory monitoring systems, and AI-enabled diagnostic solutions to improve treatment outcomes and patient adherence. Integration of artificial intelligence and remote monitoring technologies is enabling more accurate diagnosis and real-time patient management, particularly for chronic respiratory diseases.

Restraints

One of the major challenges limiting market growth is the shortage of skilled respiratory therapists and trained healthcare professionals, particularly in developing countries. In addition, limited patient adherence to long-term respiratory therapies and the high cost of advanced respiratory equipment continue to restrict product adoption in price-sensitive markets.

Impact of COVID-19

The COVID-19 pandemic had a positive impact on the respiratory devices market as the unprecedented increase in respiratory complications significantly boosted demand for ventilators, oxygen therapy equipment, pulse oximeters, masks, and respiratory monitoring devices. Increased production capacity and government investments in healthcare infrastructure further accelerated market growth during and after the pandemic.

Segmentation Analysis

By type, the therapeutic devices segment dominates the market and is expected to account for 70.64% of the global market in 2026. Growing demand for ventilators, PAP devices, inhalers, and nebulizers, along with continuous product innovation, continues to drive segment growth. Diagnostic & monitoring devices represent the second-largest segment due to increasing respiratory disease screening and monitoring.

By application, the sleep apnea segment is projected to lead the market with a 32.37% share in 2026, supported by the rising prevalence of obstructive sleep apnea and increasing adoption of advanced PAP therapy devices. COPD and asthma remain significant application areas due to the growing global burden of chronic respiratory diseases.

By end-user, home care settings are expected to dominate the market with a 43.54% share in 2026, driven by increasing demand for portable respiratory devices, remote patient monitoring, and home-based treatment solutions. Hospitals & ASCs continue to represent an important end-user segment owing to high patient admissions and critical care requirements.

Regional Insights

North America dominated the global respiratory devices market with a value of USD 10.65 billion in 2025 and is projected to reach USD 11.17 billion in 2026. The region benefits from advanced healthcare infrastructure, widespread adoption of innovative respiratory technologies, and a high prevalence of respiratory disorders. The U.S. market is projected to reach USD 10.38 billion by 2026.

Europe accounted for USD 8.68 billion in 2025 and is expected to reach USD 9.04 billion in 2026, supported by increasing cases of COPD and asthma, favorable reimbursement policies, and continuous healthcare investments.

Asia Pacific generated USD 4.46 billion in 2025 and is projected to reach USD 4.70 billion in 2026. Rising geriatric populations, expanding healthcare infrastructure, and increasing respiratory disease awareness continue to support regional growth. China, Japan, and India remain major contributors to market expansion.

Latin America and the Middle East & Africa are witnessing gradual growth due to improving healthcare access, increasing disease awareness, and government initiatives aimed at strengthening respiratory care services.

Competitive Landscape

The global respiratory devices market is highly competitive, with leading companies focusing on technological innovation, product launches, partnerships, and geographical expansion. Major players include Koninklijke Philips N.V., Medtronic, ResMed, Inc., Fisher & Paykel Healthcare Limited, Masimo, Getinge AB, GE HealthCare, and Baxter. These companies continue to invest in smart respiratory technologies, portable devices, AI-enabled monitoring systems, and advanced ventilation solutions to strengthen their market position.

Report Coverage

This report provides a comprehensive analysis of the global respiratory devices market, including market size for 2025, 2026, and 2034, key growth drivers, market trends, restraints, COVID-19 impact, segmentation by type, application, and end-user, regional analysis, competitive landscape, and recent industry developments. The report also highlights technological advancements and strategic initiatives adopted by major market participants.

Conclusion

The global respiratory devices market is expected to witness steady long-term growth, expanding from USD 26.44 billion in 2025 to USD 45.84 billion by 2034. Rising respiratory disease prevalence, increasing adoption of home healthcare, rapid technological innovation, and growing investments in healthcare infrastructure will continue to drive market expansion. As demand for smart, portable, and AI-enabled respiratory solutions increases, manufacturers focusing on innovation, accessibility, and patient-centric care are expected to strengthen their competitive position throughout the forecast period.

Segmentation By Type

  • Therapeutic Devices
    • Positive Airway Pressure (PAP) Devices
    • Airway Management Devices
    • Ventilators
    • Inhalers
    • Nebulizers
    • Others
  • Diagnostic & Monitoring Devices
    • Spirometers
    • Polysomnography Devices
    • Pulse Oximeters
    • Others
  • Consumables and Accessories
    • Masks
    • Nasal Cannula
    • Others

By Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sleep Apnea
  • Asthma
  • Infectious Diseases
  • Others

By End-User

  • Hospitals and ASCs
  • Specialty Clinics
  • Home Care Settings
  • Others

By Region

  • North America (By Type, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-User, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Respiratory Disorders, Key Countries/Region, 2025
  • 4.2. Technological Advancements in Respiratory Devices
  • 4.3. New Product Launches
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.5. Impact of COVID-19 on Global Respiratory Devices Market

5. Global Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Therapeutic Devices
      • 5.1.1.1. Positive Airway Pressure (PAP) Devices
      • 5.1.1.2. Airway Management Devices
      • 5.1.1.3. Ventilators
      • 5.1.1.4. Inhalers
      • 5.1.1.5. Nebulizers
      • 5.1.1.6. Others
    • 5.1.2. Diagnostic & Monitoring Devices
      • 5.1.2.1. Spirometers
      • 5.1.2.2. Polysomnography Devices
      • 5.1.2.3. Pulse Oximeters
      • 5.1.2.4. Others
    • 5.1.3. Consumables and Accessories
      • 5.1.3.1. Masks
      • 5.1.3.2. Nasal Cannula
      • 5.1.3.3. Others
    • 5.1.4. Market Analysis, Insights and Forecast - By Application
      • 5.1.4.1. Chronic Obstructive Pulmonary Disease (COPD)
      • 5.1.4.2. Sleep Apnea
      • 5.1.4.3. Asthma
      • 5.1.4.4. Infectious Diseases
      • 5.1.4.5. Others
    • 5.1.5. Market Analysis, Insights and Forecast - By End User
      • 5.1.5.1. Hospitals and ASCs
      • 5.1.5.2. Specialty Clinics
      • 5.1.5.3. Home Care Settings
      • 5.1.5.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Region
    • 5.2.1. North America
    • 5.2.2. Europe
    • 5.2.3. Asia Pacific
    • 5.2.4. Latin America
    • 5.2.5. Middle East & Africa

6. North America Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Therapeutic Devices
      • 6.1.1.1. Positive Airway Pressure (PAP) Devices
      • 6.1.1.2. Airway Management Devices
      • 6.1.1.3. Ventilators
      • 6.1.1.4. Inhalers
      • 6.1.1.5. Nebulizers
      • 6.1.1.6. Others
    • 6.1.2. Diagnostic & Monitoring Devices
      • 6.1.2.1. Spirometers
      • 6.1.2.2. Polysomnography Devices
      • 6.1.2.3. Pulse Oximeters
      • 6.1.2.4. Others
    • 6.1.3. Consumables and Accessories
      • 6.1.3.1. Masks
      • 6.1.3.2. Nasal Cannula
      • 6.1.3.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.2. Sleep Apnea
    • 6.2.3. Asthma
    • 6.2.4. Infectious Diseases
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals and ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Home Care Settings
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Therapeutic Devices
      • 7.1.1.1. Positive Airway Pressure (PAP) Devices
      • 7.1.1.2. Airway Management Devices
      • 7.1.1.3. Ventilators
      • 7.1.1.4. Inhalers
      • 7.1.1.5. Nebulizers
      • 7.1.1.6. Others
    • 7.1.2. Diagnostic & Monitoring Devices
      • 7.1.2.1. Spirometers
      • 7.1.2.2. Polysomnography Devices
      • 7.1.2.3. Pulse Oximeters
      • 7.1.2.4. Others
    • 7.1.3. Consumables and Accessories
      • 7.1.3.1. Masks
      • 7.1.3.2. Nasal Cannula
      • 7.1.3.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.2. Sleep Apnea
    • 7.2.3. Asthma
    • 7.2.4. Infectious Diseases
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals and ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Home Care Settings
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. France
    • 7.4.2. Italy
    • 7.4.3. Spain
    • 7.4.4. U.K.
    • 7.4.5. Germany
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Therapeutic Devices
      • 8.1.1.1. Positive Airway Pressure (PAP) Devices
      • 8.1.1.2. Airway Management Devices
      • 8.1.1.3. Ventilators
      • 8.1.1.4. Inhalers
      • 8.1.1.5. Nebulizers
      • 8.1.1.6. Others
    • 8.1.2. Diagnostic & Monitoring Devices
      • 8.1.2.1. Spirometers
      • 8.1.2.2. Polysomnography Devices
      • 8.1.2.3. Pulse Oximeters
      • 8.1.2.4. Others
    • 8.1.3. Consumables and Accessories
      • 8.1.3.1. Masks
      • 8.1.3.2. Nasal Cannula
      • 8.1.3.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 8.2.2. Sleep Apnea
    • 8.2.3. Asthma
    • 8.2.4. Infectious Diseases
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals and ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Home Care Settings
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Therapeutic Devices
      • 9.1.1.1. Positive Airway Pressure (PAP) Devices
      • 9.1.1.2. Airway Management Devices
      • 9.1.1.3. Ventilators
      • 9.1.1.4. Inhalers
      • 9.1.1.5. Nebulizers
      • 9.1.1.6. Others
    • 9.1.2. Diagnostic & Monitoring Devices
      • 9.1.2.1. Spirometers
      • 9.1.2.2. Polysomnography Devices
      • 9.1.2.3. Pulse Oximeters
      • 9.1.2.4. Others
    • 9.1.3. Consumables and Accessories
      • 9.1.3.1. Masks
      • 9.1.3.2. Nasal Cannula
      • 9.1.3.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 9.2.2. Sleep Apnea
    • 9.2.3. Asthma
    • 9.2.4. Infectious Diseases
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals and ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Home Care Settings
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Therapeutic Devices
      • 10.1.1.1. Positive Airway Pressure (PAP) Devices
      • 10.1.1.2. Airway Management Devices
      • 10.1.1.3. Ventilators
      • 10.1.1.4. Inhalers
      • 10.1.1.5. Nebulizers
      • 10.1.1.6. Others
    • 10.1.2. Diagnostic & Monitoring Devices
      • 10.1.2.1. Spirometers
      • 10.1.2.2. Polysomnography Devices
      • 10.1.2.3. Pulse Oximeters
      • 10.1.2.4. Others
    • 10.1.3. Consumables and Accessories
      • 10.1.3.1. Masks
      • 10.1.3.2. Nasal Cannula
      • 10.1.3.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 10.2.2. Sleep Apnea
    • 10.2.3. Asthma
    • 10.2.4. Infectious Diseases
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals and ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Home Care Settings
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Koninklijke Philips N.V.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Medtronic
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. ResMed, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Fisher & Paykel Healthcare Limited
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Masimo
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Getinge AG
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. GE Healthcare
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Baxter
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Respiratory Devices Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Respiratory Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
  • Table 3: Global Respiratory Devices Market Revenue (USD billion) Forecast, by Diagnostic & Monitoring Devices, 2021-2034
  • Table 4: Global Respiratory Devices Market Revenue (USD billion) Forecast, by Consumables and Accessories, 2021-2034
  • Table 5: Global Respiratory Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: Global Respiratory Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Respiratory Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Respiratory Devices Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 9: North America Respiratory Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
  • Table 10: North America Respiratory Devices Market Revenue (USD billion) Forecast, by Diagnostic & Monitoring Devices, 2021-2034
  • Table 11: North America Respiratory Devices Market Revenue (USD billion) Forecast, by Consumables and Accessories, 2021-2034
  • Table 12: North America Respiratory Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: North America Respiratory Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Respiratory Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Respiratory Devices Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 16: Europe Respiratory Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
  • Table 17: Europe Respiratory Devices Market Revenue (USD billion) Forecast, by Diagnostic & Monitoring Devices, 2021-2034
  • Table 18: Europe Respiratory Devices Market Revenue (USD billion) Forecast, by Consumables and Accessories, 2021-2034
  • Table 19: Europe Respiratory Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Europe Respiratory Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Respiratory Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
  • Table 24: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, by Diagnostic & Monitoring Devices, 2021-2034
  • Table 25: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, by Consumables and Accessories, 2021-2034
  • Table 26: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Respiratory Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 30: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
  • Table 31: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, by Diagnostic & Monitoring Devices, 2021-2034
  • Table 32: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, by Consumables and Accessories, 2021-2034
  • Table 33: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Respiratory Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 37: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
  • Table 38: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, by Diagnostic & Monitoring Devices, 2021-2034
  • Table 39: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, by Consumables and Accessories, 2021-2034
  • Table 40: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Respiratory Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Respiratory Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Respiratory Devices Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Respiratory Devices Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Respiratory Devices Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Respiratory Devices Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Respiratory Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Respiratory Devices Market Value Share (%), by Type, 2025
  • Figure 8: North America Respiratory Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Respiratory Devices Market Value Share (%), by Application, 2025
  • Figure 10: North America Respiratory Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Respiratory Devices Market Value Share (%), by End User, 2025
  • Figure 12: North America Respiratory Devices Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Respiratory Devices Market Value Share (%), By Country, 2025
  • Figure 14: Europe Respiratory Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Respiratory Devices Market Value Share (%), by Type, 2025
  • Figure 16: Europe Respiratory Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Respiratory Devices Market Value Share (%), by Application, 2025
  • Figure 18: Europe Respiratory Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Respiratory Devices Market Value Share (%), by End User, 2025
  • Figure 20: Europe Respiratory Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Respiratory Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Respiratory Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Respiratory Devices Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Respiratory Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Respiratory Devices Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Respiratory Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Respiratory Devices Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Respiratory Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Respiratory Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Respiratory Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Respiratory Devices Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Respiratory Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Respiratory Devices Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Respiratory Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Respiratory Devices Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Respiratory Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Respiratory Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Respiratory Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Respiratory Devices Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Respiratory Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Respiratory Devices Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Respiratory Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Respiratory Devices Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Respiratory Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Respiratory Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Respiratory Devices Market Share (%), By Company, 2025